HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 87 filers reported holding HARVARD BIOSCIENCE INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $197,000 | +35.9% | 45,592 | 0.0% | 0.00% | – |
| Q4 2018 | $145,000 | -69.7% | 45,592 | -50.0% | 0.00% | – |
| Q3 2018 | $478,000 | +95.9% | 91,184 | +100.0% | 0.00% | – |
| Q2 2018 | $244,000 | +73.0% | 45,592 | -2.7% | 0.00% | – |
| Q1 2016 | $141,000 | -13.5% | 46,847 | 0.0% | 0.00% | – |
| Q4 2015 | $163,000 | -7.9% | 46,847 | 0.0% | 0.00% | – |
| Q3 2015 | $177,000 | -33.7% | 46,847 | 0.0% | 0.00% | – |
| Q2 2015 | $267,000 | +26600.0% | 46,847 | +16054.1% | 0.00% | – |
| Q2 2014 | $1,000 | -99.4% | 290 | -99.1% | 0.00% | – |
| Q1 2014 | $154,000 | +1.3% | 32,425 | 0.0% | 0.00% | – |
| Q4 2013 | $152,000 | -11.1% | 32,425 | 0.0% | 0.00% | – |
| Q3 2013 | $171,000 | +11.0% | 32,425 | -0.7% | 0.00% | – |
| Q2 2013 | $154,000 | – | 32,645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,199,922 | $6,269,778 | 8.31% |
| 272 Capital LP | 1,535,820 | $4,377,087 | 2.19% |
| Meros Investment Management, LP | 835,213 | $2,380,357 | 1.13% |
| Harvey Partners, LLC | 2,557,500 | $7,288,875 | 0.88% |
| Acuitas Investments, LLC | 407,343 | $1,160,928 | 0.62% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,772,339 | $7,901,166 | 0.46% |
| BARD ASSOCIATES INC | 296,995 | $846,436 | 0.32% |
| Riverwater Partners LLC | 105,977 | $302,034 | 0.22% |
| Granahan Investment Management | 1,925,398 | $5,487,384 | 0.22% |
| HEARTLAND ADVISORS INC | 1,200,000 | $3,420,000 | 0.19% |